1. Home
  2. ARWR vs DEI Comparison

ARWR vs DEI Comparison

Compare ARWR & DEI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARWR
  • DEI
  • Stock Information
  • Founded
  • ARWR 2003
  • DEI 1971
  • Country
  • ARWR United States
  • DEI United States
  • Employees
  • ARWR N/A
  • DEI N/A
  • Industry
  • ARWR Biotechnology: Pharmaceutical Preparations
  • DEI Real Estate Investment Trusts
  • Sector
  • ARWR Health Care
  • DEI Real Estate
  • Exchange
  • ARWR Nasdaq
  • DEI Nasdaq
  • Market Cap
  • ARWR 2.5B
  • DEI 2.4B
  • IPO Year
  • ARWR 1993
  • DEI 2006
  • Fundamental
  • Price
  • ARWR $22.03
  • DEI $16.16
  • Analyst Decision
  • ARWR Buy
  • DEI Hold
  • Analyst Count
  • ARWR 8
  • DEI 10
  • Target Price
  • ARWR $43.14
  • DEI $18.11
  • AVG Volume (30 Days)
  • ARWR 2.5M
  • DEI 1.6M
  • Earning Date
  • ARWR 08-07-2025
  • DEI 08-05-2025
  • Dividend Yield
  • ARWR N/A
  • DEI 4.69%
  • EPS Growth
  • ARWR N/A
  • DEI N/A
  • EPS
  • ARWR N/A
  • DEI 0.22
  • Revenue
  • ARWR $572,976,000.00
  • DEI $1,001,173,000.00
  • Revenue This Year
  • ARWR $22,306.37
  • DEI $2.32
  • Revenue Next Year
  • ARWR N/A
  • DEI $2.17
  • P/E Ratio
  • ARWR N/A
  • DEI $74.72
  • Revenue Growth
  • ARWR 2816.20
  • DEI 3.24
  • 52 Week Low
  • ARWR $9.57
  • DEI $12.39
  • 52 Week High
  • ARWR $27.34
  • DEI $20.50
  • Technical
  • Relative Strength Index (RSI)
  • ARWR 68.08
  • DEI 63.35
  • Support Level
  • ARWR $20.45
  • DEI $14.64
  • Resistance Level
  • ARWR $22.75
  • DEI $16.11
  • Average True Range (ATR)
  • ARWR 1.05
  • DEI 0.37
  • MACD
  • ARWR 0.26
  • DEI 0.17
  • Stochastic Oscillator
  • ARWR 86.98
  • DEI 98.28

About ARWR Arrowhead Pharmaceuticals Inc.

Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.

About DEI Douglas Emmett Inc.

Douglas Emmett Inc is an integrated, self-administered, and self-managed REIT. It is an owner and operator of office and multifamily properties located in coastal submarkets in Los Angeles and Honolulu. The group focuses on owning, acquiring, developing, and managing a substantial market share of office properties and multifamily communities in neighborhoods with supply constraints, high-end executive housing, and key lifestyle amenities. Its properties are located in the Beverly Hills, Brentwood, Burbank, Century City, Olympic Corridor, Santa Monica, Sherman Oaks/Encino, Warner Center/Woodland Hills and Westwood submarkets of Los Angeles County, California, and in Honolulu, Hawaii. It has two business segments, the office segment and the multifamily segment.

Share on Social Networks: